Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders

AI Technologies In Pharma And Biotech: Interview With Bill Wallace #aiinpharma #pharmatechnology #biotechai 
Hi Everyone! Welcome to the Biotech Bytes by The Swan Group
How is AI revolutionizing patient safety, clinical trials, and adverse event monitoring? In this exclusive interview with Bill Wallace from Intercept Pharmaceuticals, we explore how AI is transforming pharma and biotech. Please visit our website to get more information: https://swangroup.net/ 
Learn how AI-powered models are enhancing pharmacovigilance, detecting data anomalies, and improving safety monitoring. Bill shares practical examples, including AI-driven chatbots and strategies to address data security challenges, while highlighting the potential of artificial intelligence in life sciences.
Discover how AI is reshaping the future of healthcare with innovative approaches that prioritize data accuracy and patient-first solutions. Watch now to uncover new perspectives on AI’s role in the pharmaceutical and biotech industries. Share your thoughts on this game-changing technology in the comments!
Specifically, this episode highlights the following themes:
✅ The integral role of AI in advancing pharmaceutical research and patient care
✅ Confronting cybersecurity challenges in an AI-enhanced pharmaceutical industry
✅ Navigating the financial and strategic landscape for AI adoption in varying company sizes
Links from this episode:
✅ Get to know more about Bill Wallace: williamwallace2  
✅ Learn more about Intercept: https://www.interceptpharma.com
👉 Don’t forget to like, subscribe, and share!
🔔𝐃𝐨𝐧'𝐭 𝐟𝐨𝐫𝐠𝐞𝐭 𝐭𝐨 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐜𝐡𝐚𝐧𝐧𝐞𝐥 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐮𝐩𝐝𝐚𝐭𝐞𝐬.
   / @biotech_bytes   
🔗 Stay Connected With Us.
Linkedin:  / the-swan-group   
Website:  https://swangroup.net/  
=============================
🎬Suggested videos for you:
▶️    • The Future Of Biotech: Blockchain, AI, And...   
▶️    • Looking at an Old Paradigm through a Diffe...   
▶️    • Back to Basics with Pasqual Zottola   
▶️    • How Data Analytics and AI Are Shaping the ...   
▶️    • Arcutis' Impactful Diversity Initiatives  
=============================
🔎 Related Phrases:
AI In Drug Research, Biotech AI Solutions, Advanced AI Pharma, AI Collaboration In Biotech, AI In Healthcare Research, Pharma AI Solutions, AI Tackling Bias, Cutting-Edge Pharma AI, AI-Driven Patient Safety, Biotech Industry Trends, AI Clinical Trial Insights, AI In Pharma Technology, Pharma Innovations 2024, Healthcare AI Applications

Empathetic AI and the Future of Work in Life Sciences #aiinlifesciences #pharmaai #biotechbytes
Artificial intelligence is shifting how biotech and pharmaceutical teams operate in the field. Rather than replacing sales reps or medical science liaisons, the real power of technology comes from making employees better at what they do. In this episode of Biotech Bytes, host Steve Swan speaks with Parth Khanna, CEO and Co-founder of ACTO, about using empathetic AI to support a bionic employee workforce. Please visit our website to get more information: https://swangroup.net/ 
Parth explains how intelligent field excellence platforms give customer-facing teams quick access to clinical data, personalized training, and real-time coaching. They discuss why human connection, trust, and strict compliance matter when introducing AI agents into healthcare.
Key topics covered in this video:
• Why AI should augment human skills instead of replacing workers
• How field reps and medical science liaisons use AI agents to prepare for calls and learn faster
• The role of compliance, governance, and trust in enterprise AI adoption
• How human judgment and AI support work together to shape the future of work
Links from this episode:
✅ Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup 
✅ Get to know more about Parth Khanna: https://www.linkedin.com/in/parthkhanna 
✅ Learn more about Acto: https://acto.com 
🔔𝐃𝐨𝐧'𝐭 𝐟𝐨𝐫𝐠𝐞𝐭 𝐭𝐨 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐜𝐡𝐚𝐧𝐧𝐞𝐥 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐮𝐩𝐝𝐚𝐭𝐞𝐬.
https://www.youtube.com/@Biotech_Bytes/?sub_confirmation=1 
🔗 Stay Connected With Us.
LinkedIn: https://www.linkedin.com/company/the-swan-group/ 
Website:  https://swangroup.net/   
=============================
🎬Suggested videos for you:
▶️ https://www.youtube.com/watch?v=CaHwarSYhrA 
▶️ https://www.youtube.com/watch?v=be8szNVFrNk 
▶️ https://www.youtube.com/watch?v=_Be6WEEy2JM 
▶️ https://www.youtube.com/watch?v=mqpB3pGywkU 
▶️ https://www.youtube.com/watch?v=w9QyuG6p3Ys
=============================
⚠️ DISCLAIMER: We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of watching any of our publications. You acknowledge that you use the information we provide at your own risk. Do your research. 
Copyright Notice: This video and our YouTube channel contain dialogue, music, and images that are the property of Biotech Bytes by The Swan Group. You are authorized to share the video link and channel and embed this video in your website or others as long as a link back to our YouTube channel is provided. 
© Biotech Bytes by The Swan Group
=============================
#aiinlifesciences #empatheticai #pharmaai #biotechbytes #bionicemployee #healthtech
How Empathetic AI is Creating Bionic Employees in Life Sciences? | Parth Khanna

How to Launch a Biotech Startup in 2025 | Real Talk with Richard Bendis #richardbendis #healthtech #entrepreneurship

What does it really take to build a successful biotech startup in today’s tough investment climate? Please visit our website to get more information: https://swangroup.net/ 

In this episode, I sit down with Richard Bendis, the powerhouse behind BioHealth Innovation, to unpack the raw reality of starting a life sciences company in 2025. From navigating non-dilutive funding and government partnerships to leveraging EIR programs and tech transfer strategies, we dive into the entrepreneurial ecosystem that’s shaping the future of biotech. 

Richard’s insights span decades of innovation policy, investment, and commercialization strategy - exactly what founders and future founders need right now. If you're looking to launch a biotech company or you're struggling with funding, this conversation is packed with practical knowledge.

Links from this episode:
✅ Get to know more about Richard Bendis:  https://www.linkedin.com/in/richbendis  
✅ Learn more about BioHealth Innovation: https://www.biohealthinnovation.org

🔔𝐃𝐨𝐧'𝐭 𝐟𝐨𝐫𝐠𝐞𝐭 𝐭𝐨 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐜𝐡𝐚𝐧𝐧𝐞𝐥 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐮𝐩𝐝𝐚𝐭𝐞𝐬.
https://www.youtube.com/@Biotech_Bytes/?sub_confirmation=1 

🔗 Stay Connected With Us.

LinkedIn: https://www.linkedin.com/company/the-swan-group/ 
Website:  https://swangroup.net/   

=============================

🎬Suggested videos for you:

▶️ https://www.youtube.com/watch?v=yF7iwNZiIis 
▶️ https://www.youtube.com/watch?v=ZWXIIe66-kI 
▶️ https://www.youtube.com/watch?v=T6EzJ1F_6pg 
▶️ https://www.youtube.com/watch?v=be8szNVFrNk 
▶️ https://www.youtube.com/watch?v=_Be6WEEy2JM 

=================================

🔎 Related Phrases:

How to Launch a Biotech Startup in 2025, Real Talk with Richard Bendis, How To Start A Biotech Company In 2025, Biotech Startup Funding Strategies, Non-Dilutive Funding For Life Sciences, Biotech Investment Trends 2025, BioHealth Innovation Richard Bendis, Early Stage Biotech Challenges, Government Funding Biotech Startups, Commercializing Biotech Research, EIR Programs In Biotech

#biotech #startups #biotechstartup #fundraising #lifesciences #biotechfunding

Data is the fuel that powers the modern world. In this video, Charles Link, Senior Director of Data and Analytics at Reworld Waste, shares insights into building a robust data infrastructure that drives sustainable growth. Please visit our website to get more information: https://swangroup.net/ 
Charles has created an award-winning data “supply chain” to support Reworld’s eco-friendly mission, ensuring that data empowers every business goal, from real-time insights to ambitious AI projects.
Join us as we explore:
How businesses can leverage strong data foundations for growth
Strategies for creating efficient, sustainable data systems
The role of ethical data practices in AI implementation
Don’t miss out on learning how data can transform industries toward a greener future! Remember to subscribe, like, and comment your thoughts on data-driven sustainability.
Links from this episode:
Get to know more about Charles Link: https://www.linkedin.com/in/charles-a-link 
Learn more about Reworld Waste: https://www.reworldwaste.com
This video is about The Power Of Data Infrastructure In Business Sustainability - Charles Link’s Strategy. But It also covers the following topics:
Charles Link Interview
Data For Environmental Impact
Data System For Companies
🔔 Stay ahead in biotech and pharma! Subscribe for exclusive industry trends, leader insights, industry leader interviews, best practices, and innovative biotech strategies!
https://www.youtube.com/@Biotech_Bytes/?sub_confirmation=1 
🔗 Stay Connected With Us.
👉 Linkedin: https://www.linkedin.com/company/the-swan-group/ 
👉 Website:  https://swangroup.net/   
=============================
🎬 WATCH OUR OTHER VIDEOS:
👉 AI Lending a Hand to Security with Kelly Randis https://www.youtube.com/watch?v=T6EzJ1F_6pg 
👉 Garbage In, Garbage Out: Science, Data, Technology with Jonathon Hill https://www.youtube.com/watch?v=be8szNVFrNk 
👉 Data is the key to AI with Keshia Maughn https://www.youtube.com/watch?v=_Be6WEEy2JM 
👉 Digital Enterprise Capabilities (DEC): Beyond IT with Matt Lasmanis 
https://www.youtube.com/watch?v=mqpB3pGywkU 
👉 Arcutis' Impactful Diversity Initiatives 
https://www.youtube.com/watch?v=w9QyuG6p3Ys 
=============================
#data #sustainability #businessgrowth #analytics #infrastructure #aiethics
© Biotech Bytes by The Swan Group

AI is moving incredibly fast across the life sciences sector, but many organizations still struggle to build systems that deliver real operational value. In this episode, tech leader Rose LaRocca-Fisch explains why strong data governance and business alignment must come before chasing software trends. Please visit our website to get more information: https://swangroup.net/ 
Rose shares her practical leadership experience guiding pharmaceutical companies, CDMOs, and global biotech organizations through massive growth. The discussion breaks down why high-profile tech implementations collapse and outlines the exact steps needed to prepare your infrastructure for enterprise-grade tools.
Key themes covered in this conversation:
Why does advanced software amplify existing operational flaws instead of fixing them
The OASIS framework for sustainable and scalable IT transformation
How data readiness directly impacts clinical trial success and manufacturing yields
Real-world applications using platforms like Databricks to speed up patient enrollment
The shift toward AI-assisted work and managing data integrity risks
Links from this episode:
Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup 
Get to know more about Rose LaRocca-Fisch: https://www.linkedin.com/in/rose-larocca-fisch 
🔔𝐃𝐨𝐧'𝐭 𝐟𝐨𝐫𝐠𝐞𝐭 𝐭𝐨 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐜𝐡𝐚𝐧𝐧𝐞𝐥 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐮𝐩𝐝𝐚𝐭𝐞𝐬.
https://www.youtube.com/@Biotech_Bytes/?sub_confirmation=1 
🔗 Stay Connected With Us.
LinkedIn: https://www.linkedin.com/company/the-swan-group/ 
Website:  https://swangroup.net/   
=============================
🎬Suggested videos for you:
▶️ https://www.youtube.com/watch?v=CaHwarSYhrA 
▶️ https://www.youtube.com/watch?v=be8szNVFrNk 
▶️ https://www.youtube.com/watch?v=_Be6WEEy2JM 
▶️ https://www.youtube.com/watch?v=mqpB3pGywkU 
▶️ https://www.youtube.com/watch?v=w9QyuG6p3Ys
=============================
#biotechai #pharmatech #lifesciences #datagovernance #clinicaltrials #ittransformation